Precision oncology solutions for liver cancer
Ophiomics was born out of a collaboration between scientists and physicians who share a desire to bring the latest advances in genomics, bioinformatics, and clinical research in support of Precision Oncology.
Ophiomics develops and offers advanced genetic and genomic tests to support diagnosis, prognosis, pharmacogenomics and clinical follow-up. We process FFPE and liquid biopsies (based on circulating cell-free DNA) to characterize the mutational landscape of tumors, providing guidance for therapy and non-invasive assessments of treatment response. We offer clinical trials to cancer centers, along with a strong emphasis on clinically-oriented research.
